Organization

Zhonglin Hao

2 clinical trials

Clinical trial

Boosting Immune Response With Copanlisib in Locally Advanced Unresectable Non-Small Cell Lung Cancer Receiving Durvalumab, A Phase Ib Study

Status: Active (not recruiting), Estimated PCD: 2025-06-01

Clinical trial

Phase II Study of Combination Rucaparib With Nivolumab in Platinum-Sensitive Small Cell Lung Carcinoma Patients as Maintenance After Induction Therapy With Platinum Doublet

Status: Active (not recruiting), Estimated PCD: 2022-11-15